SCHEMBL263892

SCHEMBL263892

O=P(O)(O)O[C@H]1C(Nc2ncc[nH]2)O[C@H](CO)[C@H]1O

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.41
FDPS P14324 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574281 0.86 ADORA1 (0.35) ADORA1
SCHEMBL4317020 0.83 ADORA1 (0.40) ADORA1FDPS
SCHEMBL769262 0.82 ADORA1 (0.45) ADORA1
SCHEMBL5063261 0.81 TSHR (0.43)
SCHEMBL1115485 0.78 ADORA1 (0.39) ADORA1
SCHEMBL5245060 0.77 ADORA1 (0.38) ADORA1
SCHEMBL860142 0.73 ADORA1 (0.37) ADORA1
SCHEMBL9893437 0.73 ADORA1 (0.35) ADORA1
SCHEMBL2819497 0.73 ADORA1 (0.39) ADORA1
SCHEMBL574712 0.73 ADORA1 (0.39) ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346910-A1 METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION COMMENSE BIO INC (US) 2025-11-13 US claimed
US-12163135-B2 Methods and compositions to prevent microbial infection BioPlx, Inc. (US) 2024-12-10 US claimed
US-20230390297-A1 USE OF NUCLEOTIDE SYNTHESIS INHIBITORS FOR TARGETED THERAPY IN MLL3/4 COMPASS MUTANT CANCER NORTHWESTERN UNIVERSITY 2023-12-07 US claimed
EP-4158010-A1 METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS BioPlx, Inc. (US) 2023-04-05 EP claimed
US-20220288135-A1 LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS BioPlx, Inc. (US) 2022-09-15 US claimed
EP-4017527-A1 COMBINATION THERAPY OF A T CELL THERAPY AND AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) INHIBITOR AND RELATED METHODS Juno Therapeutics, Inc. (US) 2022-06-29 EP claimed
CN-114555112-A Combination therapy of T cell therapy and ZESTE enhancer homolog 2(EZH2) inhibitors and related methods 朱诺治疗学股份有限公司 2022-05-27 CN claimed
US-11324787-B2 Analytical methods and arrays for use in the same SENZAGEN AB (SE) 2022-05-10 US claimed
US-20220025364-A1 METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS COMMENSE BIO, INC. 2022-01-27 US claimed
EP-3613416-B1 APPLICATIONS OF SPERMINE AND ITS DERIVATIVE IN PREPARATION OF ANTITUMOR DRUG GENEHEAL BIOTECHNOLOGY CO LTD (CN) 2021-12-15 EP claimed
EP-1668154-B1 METHODS USEFUL FOR DETECTING AN ALTERATION IN A LOCUS COPY NUMBER TRISOGEN BIOTECHNOLOGY LTD PAR (IL) 2008-11-26 EP claimed
WO-2007027919-A2 COMPLEMENTATION ASSAYS UTILIZING COMPLEXES OF HETEROPROTEINS WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2007-03-08 WO claimed
US-20070004015-A1 Novel metabolism-associated gene products from ashbya gossypii BASF AKTIENGESELLSCHAFT (DE) 2007-01-04 US claimed
US-20060148039-A1 Methylotroph producing mammalian type sugar chain KIRIN PHARMA KABUSHIKI KAISHA (JP) 2006-07-06 US claimed
US-20060040279-A1 DNA chips used for bioprocess control HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-02-23 US claimed
EP-1505149-A1 METHYLOTROPH PRODUCING MAMMALIAN TYPE SUGAR CHAIN KIRIN BEER KABUSHIKI KAISHA (JP) 2005-02-09 EP claimed
EP-0667781-B1 PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES OKLAHOMA MED RES FOUND (US) 2000-03-15 EP claimed
US-5719064-A AUTOIMMUNE DISEASES OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1998-02-17 US claimed
EP-0667781-A1 PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1995-08-23 EP claimed
WO-1994005303-A1 PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1994-03-17 WO claimed